key: cord-0886675-2zeq75ms
authors: Chang, Michelle J.; Stewart, Claire R.; Lipner, Shari R.
title: Retrospective study of nail telemedicine visits during the COVID‐19 pandemic
date: 2020-12-13
journal: Dermatol Ther
DOI: 10.1111/dth.14630
sha: ea0a88247ccbb2a63380d126434724bf1a910942
doc_id: 886675
cord_uid: 2zeq75ms

nan

The COVID-19 pandemic has resulted in rapid adoption of telemedicine, with recent teledermatology interest and recommendations. 1 Nail telemedicine has not been explored and guidelines are lacking. Our study objectives were to analyze characteristics of nail teledermatology visits and provide recommendations for virtual nail visits.

Following Weill Cornell Institutional Review Board approval (Protocol #20-03021691-01), all virtual nail visits (16 March 2020 to 5 May 2020) seen by a nail specialist (SRL) were queried from EPIC. (15%) new visits, with 6/7 requiring an in-person visit for mycological confirmation. Onychomycosis (18/50, 36%) and nail psoriasis (9/50, 18%) were the most common diagnoses for virtual follow-up visits. Inperson follow-ups were recommended for 57% of new nail conditions. New vs follow-up virtual visits were 14 times more likely to necessitate in-person visits (P < .01). Nail patients were recommended to come for office visits for clinical examination/dermoscopy (39%), nail clippings (32%), biopsies (18%), and other procedures (11%). For all visits, systemic medications were five times more likely to be reordered/continued vs started (P < .01).

More than half of new virtual visits could not be managed by telemedicine and required subsequent in-person visits ( To triage nail patients for in-person vs virtual visits most efficiently, effectively, and economically, prescreening using photographs by attending or resident dermatologists should be considered. We acknowledge that this approach requires additional physician time commitment, which may not be feasible in all practice settings. Artificial intelligence should be developed for this purpose to decrease health care costs and improve patient care. 5 Limitations include single-center, retrospective design, data from one dermatologist, and sample size. Since only one patient had an inperson follow-up during the study period, outcomes could not be analyzed.

In sum, telemedicine can be utilized to manage patients with previously diagnosed nail diseases and diagnose some new nail conditions. Patients with longitudinal melanonychia and suspected onychomycosis should be scheduled exclusively for in-person visits.

Further research in nail telemedicine is needed to analyze patient outcomes to establish more rigorous guidelines.

The authors declare no potential conflict of interest.

The data that support the findings of this study are available from the corresponding author upon reasonable request. 

Teledermatology: current indications and considerations for future use

Recommendations for diagnosis and treatment of onychomycosis during the COVID-19 pandemic

Considerations for management of longitudinal melanonychia during the coronavirus disease 2019 (COVID-19) pandemic: an international perspective

Onychotillomania: diagnosis and management

Performance of a deep neural network in teledermatology: a single-center prospective diagnostic study